论文发表概况
  发布时间:2016-03-28     来源:呼吸疾病国家重点实验室 2015年2月

 

1.20062010年重要的期刊论文

1.     JinPing Zheng, Jian Kang, ShaoGuang Huang, Ping Chen, Wan-Zen Yao, Lan Yang, Chun-Xue Bai, ChangZheng Wang, Chen Wang,BaoYuan Chen, Yi Shi, ChunTao Liu, Ping Chen, Qiang Li, ZhenShan Wang, YiJiang Huang, ZhiYang Luo, FeiPeng Chen, JianZhang Yuan,BenTong Yuan, HuiPing Qian, RongChang Zhi, NanShan Zhong.Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo controlled study. Lancet 2008;371(9629):2013-2018

2.     Jingping Zheng,Nanshan Zhong, etl Carbocisteine for acute exacerbations of COPD.(letter). Lancet 2008;372(11):1630-1631

3.      Yumin Zhou,Guoping Hu, Dali Wang, Shaoyi Wang, Yujun Wang,Zhigang Liu, Jinxin Hu, Zhe Shi, Gongyong Peng,Shengming Liu, Jiachun Lu, Jingping Zheng,Jian Wang, Nanshan Zhong, Pixin Ran. Community-Based Integrated Intervention for Prevention and management of Chronic Obstructive Pulmonary Disease inGuangdong, China, a Cluster Randomised Control Trial. British Medical Journal 2010; Published 1 December 2010

4.     Nanshan Zhong, Chen Wang, Wanzhen Yao, Ping Chen, Jian Kang, Shaoguang Huang, Baoyuan Chen,Changzheng Wang, Diantao Ni9, Yumin Zhou, Shengming Liu, Xiaoping Wang, Dali Wang, Jiachun Lu,Jingping Zheng, and Pixin Ran Prevalence of Chronic Obstructive Pulmonary Disease in ChinaA Large, Population-based Survey. American Journal Respiratory and Critical Care Medicine 2007;176(11):753-760

5.  JingPing Zheng, L Yang, YM Wu; Ping Chen, ZG Wen, WJ Huang; NanShan Zhong.The efficacy and safety of combination salmeterol (50 μg) / fluticasone propionate (500 μg) inhalation twice daily via Accuhalar in Chinese patients with COPD. Chest 2007;132(6): 1756-1763

6.  Yinyin Qin, Joerg SteierPHD, Caroline JolleyMD, John MoxhamMD, Nanshan ZhongMD,Yuanming LuoPHD. Efficiency of neural drive during exercise in patients with COPD and healthy subjects. Chest 2010;138(6):1309-1315

7.   Y. Zhou, C. Wang, W. Yao, P. Chen, J. Kang, S. Huang, B. Chen, C. Wang, D. Ni,X. Wang, D. Wang, S. Liu, J. Lu, J. Zheng, Nanshan Zhong and Pixin Ran.Chronic Obstructive Pulmonary Disease in Chinese Nonsmokers . The European Respiratory Journal 2009;33(3): 509-518

2.2014年发表文章

序号

论文题目

发表刊物

第一作者

通讯作者

1

Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study

PLoS Med

Zhou Y

冉丕鑫

2

Effects of a functional variant c.353T>C in snai1 on risk of two contextual diseases. Chronic obstructive pulmonary disease and lung cancer.

American journal of respiratory and critical care medicine

杨磊

吕嘉春

3

Roflumilast for the Treatment of COPD in an Asian Population. A Randomized, Double-Blind, Parallel-Group Study

Chest

郑劲平

钟南山

4

Effect of noninvasive proportional assist vs pressure support ventilation on neuroventilatory coupling in chronic obstructive pulmonary patients with hypercapnia

Intensive care medicine

Zhang J

陈荣昌

5

Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population

Mutagenesis

王辉

吕嘉春

6

Nicotine elevated intracellular Ca² in rat airway smooth muscle cells via activating and up-regulating α7-nicotinic acetylcholine receptor

Cell Physiol Biochem

Jiang Y

冉丕鑫

365bet的钱是从哪里

7

Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial

BMJ Open

Li X

冉丕鑫

8

Twitch Mouth Pressure and Disease Severity in Subjects With COPD

Respiratory Care

巨春蓉

陈荣昌

9

Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease

 Internal Medical Journal

Chen Rui

陈荣昌

10

Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease

EXPERIMENTAL AND THERAPEUTIC MEDICINE

柳威

陈荣昌

11

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

Lancet Respir Med

郑劲平

钟南山

 

 

相关信息:
科研成果
呼吸疾病国家重点实验室2015年度学术委员会圆满召开
广东省40岁以上人群慢阻肺患病率超14%
承担科研课题任务(一)